SMLR - NASDAQ
Semler Scientific, Inc.
$20.33
+0.0000%Semler Scientific, Inc. provides technology solutions to improve the clinical effectiveness and efficiency of healthcare providers in the United States. The company's products include QuantaFlo, a four-minute in-office blood flow test that enables healthcare providers to use blood flow measurements as part of their examinations of a patient's vascular condition. Its products serve cardiologists, internists, nephrologists, endocrinologists, podiatrists, and family practitioners, as well as healthcare insurance plans, integrated delivery networks, independent physician groups, and companies contracting with the healthcare industry, such as risk assessment groups. The company offers its products through salespersons and distributors. Semler Scientific, Inc. was incorporated in 2007 and is headquartered in Santa Clara, California.
At a Glance
Live SnapshotSemler Scientific, Inc. Profit Bridge
Profitability Analysis
Gross Margin
Exceptional pricing power and cost management. The company retains over half of revenue after direct costs.
Operating Margin
Outstanding operational efficiency. The company generates substantial profit from core operations.
Net Profit Margin
Exceptional profitability. The company converts a significant portion of revenue to bottom-line earnings.
Effective Tax Rate
Below-average tax rate suggests effective tax planning, favorable jurisdictions, or tax credits.
Profitability Insight
Exceptional profitability across all levels: Strong pricing power, efficient operations, and healthy bottom line indicate a high-quality business with sustainable competitive advantages.
Semler Scientific, Inc. Income Statement
SMLR • NASDAQ
| Semler Scientific, Inc. Income Statement | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 | Dec 2020 | Dec 2019 | Dec 2018 | Dec 2017 | Dec 2016 | Dec 2015 | Dec 2014 | Dec 2013 | Dec 2012 | Dec 2011 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
REVENUE | ||||||||||||||
56.3M | 68.2M | 56.7M | 53M | 38.6M | 32.8M | 21.5M | 12.5M | 7.4M | 7M | 3.6M | 2.3M | 1.2M | 316K | |
GROSS PROFIT | ||||||||||||||
(4.8M) | (7M) | (4.3M) | (6.1M) | (3.4M) | (3.7M) | (2.7M) | (2.6M) | (1.9M) | (2.8M) | (692K) | (469K) | (364K) | (145K) | |
51.5M | 61.2M | 52.4M | 46.9M | 35.2M | 29.1M | 18.8M | 9.9M | 5.6M | 4.2M | 2.9M | 1.8M | 835K | 171K | |
OPERATING INCOME | ||||||||||||||
(30.6M) | (38.9M) | (35.2M) | (27.5M) | (19.3M) | (18.4M) | (13.4M) | (10.8M) | (7.7M) | (12.6M) | (7.3M) | (3.9M) | (3.3M) | (2M) | |
(25.8M) | (32.4M) | (30.4M) | (23.7M) | (16.3M) | (15.9M) | (11.4M) | (8.9M) | (6.9M) | (11.1M) | (6.2M) | (3.6M) | (3M) | (1.7M) | |
(4.8M) | (5.8M) | (4.8M) | (3.8M) | (2.9M) | (2.5M) | (2.1M) | (1.8M) | (866K) | (1.4M) | (1.1M) | (356K) | (277K) | (246K) | |
20.9M | 22.3M | 17.2M | 19.4M | 16M | 10.7M | 5.3M | -853K | -2.2M | -8.4M | -4.3M | -2.1M | -2.4M | -1.8M | |
PRE-TAX INCOME | ||||||||||||||
(0.0) | (0.0) | (0.0) | (0.0) | (0.0) | (0.0) | (298K) | (464K) | (391K) | (86K) | (175K) | (108K) | (120K) | (64K) | |
1.9M | 2.5M | 494K | 10K | 19K | 2K | -298K | -464K | -391K | -86K | -175K | -108K | -120K | -64K | |
(0.0) | (734K) | (0.0) | (0.0) | (0.0) | -9K | -4K | -14K | (0.0) | -82K | (1K) | -1K | (0.0) | (0.0) | |
27M | 1.8M | 489K | 10K | 525K | -7K | -302K | -657K | -395K | -82K | -174K | -109K | -323K | -95K | |
47.9M | 24.1M | 17.7M | 19.5M | 16.5M | 10.7M | 5M | -1.5M | -2.6M | -8.5M | -4.5M | -2.2M | -2.7M | -1.9M | |
NET INCOME | ||||||||||||||
(7M) | (3.5M) | (3.4M) | (2.2M) | (2.5M) | -4.4M | (26K) | (0.0) | (0.0) | (0.0) | -20K | (0.0) | (3K) | (2K) | |
40.9M | 20.6M | 14.3M | 17.2M | 14M | 15.1M | 5M | -1.5M | -2.6M | -8.5M | -4.5M | -2.2M | -2.7M | -1.9M |
SEC Filings
SMLR - Filing history and reports
| Filing Type | Filing Date | Period Ending | Fiscal Year | Actions |
|---|---|---|---|---|
8-K 8-K 2026 N/A | January 16, 2026 | January 16, 2026 | 2026 | |
8-K 8-K 2026 N/A | January 13, 2026 | January 13, 2026 | 2026 | |
8-K 8-K 2025 N/A | December 12, 2025 | December 11, 2025 | 2025 | |
8-K 8-K 2025 N/A | November 14, 2025 | November 14, 2025 | 2025 | |
10-Q 10-Q 2025 Q3 Q3 | November 12, 2025 | September 30, 2025 | 2025 | |
8-K 8-K 2025 N/A | November 12, 2025 | November 12, 2025 | 2025 | |
8-K 8-K 2025 N/A | November 10, 2025 | November 10, 2025 | 2025 | |
8-K 8-K 2025 N/A | November 06, 2025 | November 06, 2025 | 2025 | |
8-K 8-K 2025 N/A | October 17, 2025 | October 16, 2025 | 2025 | |
8-K 8-K 2025 N/A | October 03, 2025 | October 03, 2025 | 2025 |
Related Guides
Continue your SMLR research with focused valuation guides.
Research Paths
Snapshot
Start with context, operating signals, and key market metrics.
Value Model
Stress test fair value across bear, base, and bull assumptions.
Statements
Validate revenue quality, margins, and balance sheet durability.
Earnings Call
Read management commentary and compare it with reported outcomes.
Dividends
Check payout sustainability and long-term distribution behavior.
Analyst Expectations
Review consensus spread and where estimate risk is concentrated.